ACRAL MELANOMA
Clinical trials for ACRAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ACRAL MELANOMA trials appear
Sign up with your email to follow new studies for ACRAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple drug attack on melanoma: new trial hopes to boost surgery success
Disease control Not yet recruitingThis phase 2 trial tests three immune-boosting drugs (cemiplimab, fianlimab, and ipilimumab) given before surgery in 20 people with advanced but removable melanoma. The goal is to see if the combination is safe and can shrink tumors, potentially improving outcomes. Participants m…
Matched conditions: ACRAL MELANOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New Triple-Drug attack before surgery shows promise for tough skin cancer
Disease control Not yet recruitingThis study tests whether giving three drugs (pucotenlimab, lenvatinib, and temozolomide) before surgery can shrink tumors in people with a specific type of skin cancer called acral melanoma, which is stage IIB or III and can be removed. About 30 adults will receive the drug combi…
Matched conditions: ACRAL MELANOMA
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for rare melanomas? drug combo enters phase 2 trial
Disease control Not yet recruitingThis study tests a combination of two experimental drugs (iparomlimab and tuvoraleimab) plus standard chemotherapy for people with advanced acral or mucosal melanoma, rare and aggressive skin cancers. About 48 adults who have had little or no prior treatment will receive the ther…
Matched conditions: ACRAL MELANOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC